Literature DB >> 14636827

Concentration-dependent bifunctional effect of TGF-beta 1 on immunoglobulin production: a role for Smad3 in IgA production in vitro.

Susan C McKarns1, John J Letterio, Norbert E Kaminski.   

Abstract

Injury to the liver results in rapid induction of transforming growth factor-beta1 (TGF-beta(1)) consistent with a role for TGF-beta(1) in repairing damaged tissue. In addition to its ubiquitous role in injury repair, TGF-beta(1) is also well established as a critical regulator of immune homeostasis; however, its mechanisms of action remain enigmatic. We have previously demonstrated that the hepatotoxic chlorinated hydrocarbon, carbon tetrachloride, suppresses helper T-lymphocyte function in a TGF-beta(1)-dependent manner. Here, we report that, in opposition to its immunosuppressive effects at picomolar concentrations, femtomolar concentrations of TGF-beta(1) augment T cell-dependent anti-sRBC IgM antibody forming cell (AFC) and T cell-independent DNP-Ficoll-induced AFC responses. These data support a concentration-dependent bifunctional effect by TGF-beta(1) on humoral immune responses in vitro. We further investigated a putative mechanistic role for Smad3, an intracellular mediator of TGF-beta(1) signaling, in propagating the inhibitory effects of TGF-beta(1) on humoral immune responses. Relative to wild type littermates, splenocytes from mice homologous for a null mutation in the gene encoding the TGF-beta receptor-activated Smad3 (Smad3(Exon8-/-)) were less sensitive to inhibition by TGF-beta(1) following anti-sRBC- and LPS-sensitization in vitro. In agreement, inhibition of IgM protein production by TGF-beta(1) was also dampened in LPS-sensitized Smad3(Exon8-/-) splenic B cells. Moreover, stimulation of IgA by TGF-beta(1) was abrogated in LPS-sensitized Smad3(Exon8-/-) splenocytes suggesting an additional role for Smad3 in regulating IgA production in vitro. Our results suggest that the effects of TGF-beta(1) on humoral immune responses fundamentally differ in a concentration-dependent manner and are mediated, in part, through Smad3 signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636827     DOI: 10.1016/j.intimp.2003.08.001

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  9 in total

1.  Regulation of hepatic sulfotransferase (SULT) 1E1 expression and effects on estrogenic activity in cystic fibrosis (CF).

Authors:  Charles N Falany; Dongning He; Li Li; Josie L Falany; Teresa W Wilborn; Thomas A Kocarek; Melissa Runge-Morris
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03-03       Impact factor: 4.292

2.  TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs.

Authors:  Tao Huang; Laurent David; Valentín Mendoza; Yong Yang; Maria Villarreal; Keya De; LuZhe Sun; Xiaohong Fang; Fernando López-Casillas; Jeffrey L Wrana; Andrew P Hinck
Journal:  EMBO J       Date:  2011-03-18       Impact factor: 11.598

3.  Identification of sequence variants influencing immunoglobulin levels.

Authors:  Stefan Jonsson; Gardar Sveinbjornsson; Aitzkoa Lopez de Lapuente Portilla; Bhairavi Swaminathan; Rosina Plomp; Gillian Dekkers; Ram Ajore; Mina Ali; Arthur E H Bentlage; Evelina Elmér; Gudmundur I Eyjolfsson; Sigurjon A Gudjonsson; Urban Gullberg; Arnaldur Gylfason; Bjarni V Halldorsson; Markus Hansson; Hilma Holm; Åsa Johansson; Ellinor Johnsson; Aslaug Jonasdottir; Bjorn R Ludviksson; Asmundur Oddsson; Isleifur Olafsson; Sigurgeir Olafsson; Olof Sigurdardottir; Asgeir Sigurdsson; Lilja Stefansdottir; Gisli Masson; Patrick Sulem; Manfred Wuhrer; Anna-Karin Wihlborg; Gudmar Thorleifsson; Daniel F Gudbjartsson; Unnur Thorsteinsdottir; Gestur Vidarsson; Ingileif Jonsdottir; Björn Nilsson; Kari Stefansson
Journal:  Nat Genet       Date:  2017-06-19       Impact factor: 38.330

4.  TGF-β isoforms inhibit IGF-1-induced migration and regulate terminal differentiation in a cell-specific manner.

Authors:  Elske J Schabort; Mathilde van der Merwe; Carola U Niesler
Journal:  J Muscle Res Cell Motil       Date:  2011-02-06       Impact factor: 2.698

5.  Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.

Authors:  Samiran Saha; Tuhina Mazumdar; Khairul Anam; Rajesh Ravindran; Bibhas Bairagi; Bibhuti Saha; Ramapada Goswami; Netai Pramanik; Subhashis K Guha; Sourjya Kar; Dwijadas Banerjee; Nahid Ali
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

6.  Neonatal bacillus Calmette-Guérin vaccination inhibits de novo allergic inflammatory response in mice via alteration of CD4+CD25+ T-regulatory cells.

Authors:  Qian Li; Hua-hao Shen
Journal:  Acta Pharmacol Sin       Date:  2008-12-08       Impact factor: 6.150

7.  Identification of an activation-related protein in B cells in the ABO incompatible condition.

Authors:  Jingsong Cao; Cong Chen; Luogen Liu; Yunsheng Zhang; Hong Zhou; Jianhua Xiao; Yi Wang
Journal:  Exp Ther Med       Date:  2019-11-22       Impact factor: 2.447

8.  uPAR and cathepsin B shRNA impedes TGF-β1-driven proliferation and invasion of meningioma cells in a XIAP-dependent pathway.

Authors:  V R Gogineni; R Gupta; A K Nalla; K K Velpula; J S Rao
Journal:  Cell Death Dis       Date:  2012-12-06       Impact factor: 8.469

Review 9.  Reevaluation of Pluripotent Cytokine TGF-β3 in Immunity.

Authors:  Toshihiko Komai; Tomohisa Okamura; Mariko Inoue; Kazuhiko Yamamoto; Keishi Fujio
Journal:  Int J Mol Sci       Date:  2018-08-01       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.